DATE & LOCATION
Friday, May 15, 2020, 8:00 AM – 3:45 PM, Omni New Haven Hotel, New Haven, CT
MS is the most frequent non-traumatic cause for disability among young adults in North America and Europe. Worldwide, about 2.5 million people are affected. In the United States alone, almost 1 million individuals suffer from MS. There have been tremendous strides taken in the field of multiple sclerosis over the past several years including new diagnostic criteria new treatment strategies.
This one-day meeting is designed to educate clinicians and other health care professionals on advances in the diagnosis and management of patients with multiple sclerosis.
- Examine the current understanding of the genetic basis of multiple sclerosis
- Discuss new and emerging treatment in MS and the risk benefit ratio of newer agents compared to older therapies
- Review updates on women’s health and reproductive care in MS
- Discuss how current and future biomarkers might create individualized treatment plans
- Explore current MS apps and technology to better educate and evaluate patients
Family Practice, General Practice, Hospitalist, Infectious Diseases, Internal Medicine, Multiple Specialties, Neurology, Nurse Practitioner, Nutrition, Ophthalmology, Physician Assistant